Initiatives for developing and comparing genotype interpretation systems: external validation of existing rule-based interpretation systems for abacavir against virological response†-Reference-Cited by-同舟云学术

Initiatives for developing and comparing genotype interpretation systems: external validation of existing rule-based interpretation systems for abacavir against virological response†

Published:2008-01-10 Issue:1 Volume:9 Page:27-40
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:

Author:

Cozzi-Lepri A,

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1293.2008.00523.x/fullpdf

Reference51 articles.

1. Comparison of nine resistance interpretation systems for HIV-1 genotyping;Sturmer;Antiviral Ther,2003

2. Clinically relevant interpretation of genotype for resistance to abacavir;Brun-Vezinet;AIDS,2003

3. An updated guide to genotype interpretation;MacArthur;AIDS Reader,2004

4. Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes;De Luca;Antivir Ther,2004

5. http://hivdb.stanford.edu/

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lasso regularization for left-censored Gaussian outcome and high-dimensional predictors;BMC Medical Research Methodology;2018-12

2. Sequence and Phenotypic Analysis for Resistance Monitoring in Hepatitis C Virus Drug Development: Recommendations From the HCV DRAG;Gastroenterology;2011-03

3. Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models;PLoS ONE;2010-10-29

4. Rate of Accumulation of Thymidine Analogue Mutations in Patients Continuing to Receive Virologically Failing Regimens Containing Zidovudine or Stavudine: Implications for Antiretroviral Therapy Programs in Resource‐Limited Settings;The Journal of Infectious Diseases;2009-09

5. Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting;Journal of Antimicrobial Chemotherapy;2009-07-19